Chief Commercial Officer

Certain Restricted Stock Units of Cogent Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 7-SEP-2025.

Transcript : Cogent Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

Cogent Biosciences Announces Participation in the Citi Biopharma Conference

Senior Manager, Medical Writing

Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The successful candidate will lead the planning, authoring, reviewing, and QC of clinical and regulatory documents while collaborating with cross-functional teams and overseeing contract writers.

Sign up with Google

Sign in with Google